Rising drug costs and opaque PBM practices are forcing employers to treat prescription benefits as enterprise risk.
Paul
Pruitt
Paul Pruitt
Paul Pruitt is chief growth officer at SHARx.
He works with benefit advisers to lower the cost of medications for employers and their members.
